Literature DB >> 28251372

A decrease in the prognostic nutritional index is associated with a worse long-term outcome in gastric cancer patients undergoing neoadjuvant chemotherapy.

Kazuhiro Migita1, Sohei Matsumoto2, Kohei Wakatsuki2, Masahiro Ito2, Tomohiro Kunishige2, Hiroshi Nakade2, Mutsuko Kitano2, Mitsuhiro Nakatani2, Hiromichi Kanehiro2.   

Abstract

PURPOSE: The aim of this study was to evaluate the prognostic impact of the prognostic nutritional index (PNI) in gastric cancer patients undergoing neoadjuvant chemotherapy (NAC).
METHODS: This study reviewed 54 patients with gastric cancer who underwent NAC and a subsequent R0 gastrectomy. The PNI before starting NAC and before gastrectomy were calculated using the following formula: 10 × serum albumin (g/dl) + 0.005 × total lymphocyte count (per mm3). A multivariate analysis was performed to identify the predictors of overall survival (OS).
RESULTS: The mean pre-NAC and preoperative PNI were 48.3 ± 5.1 and 48.2 ± 4.7, respectively (p = 0.934). The PNI decreased after NAC in 31 patients (57.4%). The pre-NAC PNI and preoperative PNI were not significantly associated with the OS rate. The 3-year OS rate in patients with the decreased PNI values was significantly lower than that in the patients whose PNI values were either maintained or increased (41 vs. 76.4%, p = 0.003). A multivariate analysis revealed that a decreased PNI value was an independent predictor of a poor OS (p = 0.006).
CONCLUSIONS: Decreased PNI values were associated with worse long-term outcomes in gastric cancer patients undergoing NAC.

Entities:  

Keywords:  Gastric cancer; Neoadjuvant chemotherapy; Prognostic nutritional index

Mesh:

Year:  2017        PMID: 28251372     DOI: 10.1007/s00595-017-1469-y

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  28 in total

1.  Novel immunological and nutritional-based prognostic index for gastric cancer.

Authors:  Kai-Yu Sun; Jian-Bo Xu; Shu-Ling Chen; Yu-Jie Yuan; Hui Wu; Jian-Jun Peng; Chuang-Qi Chen; Pi Guo; Yuan-Tao Hao; Yu-Long He
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

2.  Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy.

Authors:  Rachel A Murphy; Marina Mourtzakis; Quincy S C Chu; Vickie E Baracos; Tony Reiman; Vera C Mazurak
Journal:  Cancer       Date:  2011-02-28       Impact factor: 6.860

3.  Postoperative prognostic nutritional index change is an independent predictor of survival in patients with small hepatocellular carcinoma.

Authors:  Wei Peng; Chuan Li; Tian-Fu Wen; Lv-Nan Yan; Bo Li; Wen-Tao Wang; Jia-Yin Yang; Ming-Qing Xu
Journal:  Am J Surg       Date:  2015-08-24       Impact factor: 2.565

4.  Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?

Authors:  H J Andreyev; A R Norman; J Oates; D Cunningham
Journal:  Eur J Cancer       Date:  1998-03       Impact factor: 9.162

5.  Nutrition support can bring survival benefit to high nutrition risk gastric cancer patients who received chemotherapy.

Authors:  Miaozhen Qiu; Yi-xin Zhou; Yin Jin; Zi-xian Wang; Xiao-li Wei; Hong-yu Han; Wen-feng Ye; Zhi-wei Zhou; Dong-sheng Zhang; Feng-hua Wang; Yu-hong Li; Da-jun Yang; Rui-hua Xu
Journal:  Support Care Cancer       Date:  2014-12-11       Impact factor: 3.603

6.  The natural history of gastric cancer and prognostic factors influencing survival.

Authors:  A Y Bedikian; T T Chen; N Khankhanian; L K Heilbrun; C M McBride; M J McMurtrey; G P Bodey
Journal:  J Clin Oncol       Date:  1984-04       Impact factor: 44.544

7.  Predictive Potential of Preoperative Nutritional Status in Long-Term Outcome Projections for Patients with Gastric Cancer.

Authors:  Katsunobu Sakurai; Masaichi Ohira; Tatsuro Tamura; Takahiro Toyokawa; Ryosuke Amano; Naoshi Kubo; Hiroaki Tanaka; Kazuya Muguruma; Masakazu Yashiro; Kiyoshi Maeda; Kosei Hirakawa
Journal:  Ann Surg Oncol       Date:  2015-08-26       Impact factor: 5.344

8.  Weight gain as an indicator of response to chemotherapy for oesophageal carcinoma.

Authors:  R S Steyn; I Grenier; S J Darnton; M H Cullen; H R Matthews
Journal:  Clin Oncol (R Coll Radiol)       Date:  1995       Impact factor: 4.126

9.  Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis.

Authors:  A Tsuburaya; J Mizusawa; Y Tanaka; N Fukushima; A Nashimoto; M Sasako
Journal:  Br J Surg       Date:  2014-03-25       Impact factor: 6.939

10.  Individualized nutrition intervention is of major benefit to colorectal cancer patients: long-term follow-up of a randomized controlled trial of nutritional therapy.

Authors:  Paula Ravasco; Isabel Monteiro-Grillo; Maria Camilo
Journal:  Am J Clin Nutr       Date:  2012-11-07       Impact factor: 7.045

View more
  6 in total

1.  The clinical value and usage of inflammatory and nutritional markers in survival prediction for gastric cancer patients with neoadjuvant chemotherapy and D2 lymphadenectomy.

Authors:  Ziyu Li; Shuangxi Li; Xiangji Ying; Lianhai Zhang; Fei Shan; Yongning Jia; Jiafu Ji
Journal:  Gastric Cancer       Date:  2020-02-18       Impact factor: 7.370

2.  Prognostic Value of Postoperative Neutrophil and Albumin: Reassessment One Month After Gastric Cancer Surgery.

Authors:  Ali Guner; Minah Cho; Yoo-Min Kim; Jae-Ho Cheong; Woo Jin Hyung; Hyoung-Il Kim
Journal:  Front Oncol       Date:  2021-03-23       Impact factor: 6.244

3.  The therapeutic strategy for advanced gastric cancer with pyloric stenosis and liver metastasis; successfully treated by gastro-jejunal bypass and chemotherapy first, followed by curative R0 resection.

Authors:  Naosuke Nakamichi; Masahiro Tsujiura; Tomohiro Matsui; Taiga Yamamoto; Ayana Yoshioka; Hidekazu Hiramoto; Yoshimi Ouchi; Takeshi Ishimoto; Toshiyuki Kosuga; Satoshi Mochizuki; Susumu Nakashima; Masamichi Bamba; Mamoru Masuyama; Eigo Otsuji
Journal:  Surg Case Rep       Date:  2021-01-06

4.  Laparoscopic Gastrojejunostomy with Conversion Therapy in Gastric Outlet Obstruction Caused by Incurable Advanced Gastric Cancer.

Authors:  Chuandong Wang; Shengtao Lin; Xiaojuan Zhang; Changshun Yang; Weihua Li
Journal:  Cancer Manag Res       Date:  2021-09-01       Impact factor: 3.989

5.  Superiority of Laparoscopic Gastrojejunostomy Combined With Multimodality Therapy for Gastric Outlet Obstruction Caused by Advanced Gastric Cancer.

Authors:  Chuandong Wang; Xiaojuan Zhang; Shengtao Lin; Changshun Yang; BiaoHuan Zhou; Yulong Mi; Rong Ye; Yifan Chen; Weijie Chen; Xiaojun Lin; Song Tan; Yuhang Zhou; Weihua Li
Journal:  Front Oncol       Date:  2022-01-28       Impact factor: 6.244

6.  Lymph node ratio is a prospective prognostic indicator for locally advanced gastric cancer patients after neoadjuvant chemotherapy.

Authors:  Qi Jiang; Xiangyu Zeng; Chenggang Zhang; Ming Yang; Jun Fan; Gan Mao; Qian Shen; Yuping Yin; Weizhen Liu; Kaixiong Tao; Peng Zhang
Journal:  World J Surg Oncol       Date:  2022-08-17       Impact factor: 3.253

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.